Schultz NM - Search Results

1

Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer.

George DJ, Ramaswamy K, Huang A, Russell D, Mardekian J, Schultz NM, Janjan N, Freedland SJ. George DJ, et al. Among authors: schultz nm. Prostate Cancer Prostatic Dis. 2022 Sep;25(3):524-530. doi: 10.1038/s41391-021-00463-9. Epub 2021 Nov 3. Prostate Cancer Prostatic Dis. 2022. PMID: 34732856 Free PMC article.

2

Letter--Corrected Net Health Benefit Calculations for Enzalutamide Using ASCO Value Framework Guidelines and NCCN Evidence Blocks.

Flanders S, Brown B, Massoudi M, Schultz N, Ramaswamy K. Flanders S, et al. J Manag Care Spec Pharm. 2017 Nov;23(11):1202. doi: 10.18553/jmcp.2017.23.11.1202. J Manag Care Spec Pharm. 2017. PMID: 29083976 Free PMC article.

3

Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.

Schwartz KL, Simon MS, Bylsma LC, Ruterbusch JJ, Beebe-Dimmer JL, Schultz NM, Flanders SC, Barlev A, Fryzek JP, Quek RGW. Schwartz KL, et al. Among authors: schultz nm. Cancer. 2018 May 15;124(10):2104-2114. doi: 10.1002/cncr.31299. Epub 2018 Mar 5. Cancer. 2018. PMID: 29505670 Free PMC article.

4

Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.

Schultz NM, Shore ND, Chowdhury S, Klotz LH, Concepcion RS, Penson DF, Karsh LI, Yang H, Brown BA, Barlev A, Flanders SC. Schultz NM, et al. BMC Urol. 2018 Sep 6;18(1):77. doi: 10.1186/s12894-018-0387-7. BMC Urol. 2018. PMID: 30189902 Free PMC article.

5

Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis.

Schultz NM, Flanders SC, Wilson S, Brown BA, Song Y, Yang H, Lechpammer S, Kassabian V. Schultz NM, et al. Adv Ther. 2018 Oct;35(10):1639-1655. doi: 10.1007/s12325-018-0774-1. Epub 2018 Sep 6. Adv Ther. 2018. PMID: 30191463 Free PMC article.

6

Health Care Resource Utilization and Costs Associated with Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims Analysis.

Schultz NM, Penson DF, Wilson SD, Song Y, Yang H, Ramaswamy K, Lowentritt B. Schultz NM, et al. J Manag Care Spec Pharm. 2019 Aug;25(8):889-897. doi: 10.18553/jmcp.2019.19109. Epub 2019 Jun 7. J Manag Care Spec Pharm. 2019. PMID: 31172866 Free PMC article.

7

Adverse Events Associated with Cumulative Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims Analysis.

Schultz NM, Penson DF, Wilson S, Song Y, Yang H, Ramaswamy K, Lowentritt B. Schultz NM, et al. Drug Saf. 2020 Jan;43(1):23-33. doi: 10.1007/s40264-019-00867-6. Drug Saf. 2020. PMID: 31587137

8

Budget Impact of Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer.

Schultz NM, O'Day K, Sugarman R, Ramaswamy K. Schultz NM, et al. J Manag Care Spec Pharm. 2020 Apr;26(4):538-549. doi: 10.18553/jmcp.2020.19329. Epub 2020 Feb 5. J Manag Care Spec Pharm. 2020. PMID: 32020841 Free PMC article.

9

Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus Prednisone.

Ramaswamy K, Lechpammer S, Mardekian J, Huang A, Schultz NM, Sandin R, Wang L, Baser O, George DJ. Ramaswamy K, et al. Among authors: schultz nm. Adv Ther. 2020 May;37(5):2083-2097. doi: 10.1007/s12325-020-01260-x. Epub 2020 Feb 28. Adv Ther. 2020. PMID: 32112280 Free PMC article.

10

Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate.

Tagawa ST, Ramaswamy K, Huang A, Mardekian J, Schultz NM, Wang L, Sandin R, Lechpammer S, George DJ. Tagawa ST, et al. Among authors: schultz nm. Prostate Cancer Prostatic Dis. 2021 Dec;24(4):1032-1040. doi: 10.1038/s41391-021-00318-3. Epub 2021 Feb 21. Prostate Cancer Prostatic Dis. 2021. PMID: 33612825 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page